Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
October 21, 2022 at 11:00 AM EDT
More NewsView More
Buffett’s Cash Hoard Signals Market Caution, Value Plays Emerge
Today 19:07 EDT
DLocal Stock Soars 43% After Earnings Beat and Raised Guidance
Today 18:38 EDT
Can AI Defense Contracts Push Palantir Shares Higher?
Today 17:31 EDT
D-Wave Buying Spree: Will These Firms Be Potential Targets?
Today 16:32 EDT
Home Depot Holds Gains After Narrow Q2 Misses
Today 16:04 EDT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|
